EUVIMEDEUVIMED entdecken
Crossref

Latest Clinical Evidence in Extensive-Stage Small Cell Lung Cancer Treatment

Stephanie McDonald, MSN, FNP-BC, AOCNP, Elizabeth Castronovo, MSN, AGNP-BC

Journal of the Advanced Practitioner in Oncology · 27.02.2026 · 17 (2)

DOI: 10.6004/jadpro.2026.17.2.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 27.02.2026. Verfasst von Stephanie McDonald und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extensive-stage small cell lung cancer is an aggressive malignancy with historically poor survival outcomes. At JADPRO Live, presenters highlighted recent advances that are reshaping the management of this disease. Practical guidance focused on recognizing and managing oncologic emergencies, chemotherapy-related toxicities, immune-related adverse events, and novel toxicities associated with bispecific T-cell engagers, with a focus on patient and caregiver education.

Zitieren

APA

McDonald, S., MSN, FNP-BC, AOCNP, Castronovo, E., MSN, & AGNP-BC (2026). Latest Clinical Evidence in Extensive-Stage Small Cell Lung Cancer Treatment. Journal of the Advanced Practitioner in Oncology, 17(2). https://doi.org/10.6004/jadpro.2026.17.2.10

Vancouver

McDonald S, MSN, FNP-BC, AOCNP, Castronovo E, MSN, et al. Latest Clinical Evidence in Extensive-Stage Small Cell Lung Cancer Treatment. Journal of the Advanced Practitioner in Oncology. 2026;17(2). doi:10.6004/jadpro.2026.17.2.10

BibTeX
@article{McDonald2026,
  author = {McDonald, Stephanie and MSN and FNP-BC and AOCNP and Castronovo, Elizabeth and MSN and AGNP-BC},
  title = {Latest Clinical Evidence in Extensive-Stage Small Cell Lung Cancer Treatment},
  journal = {Journal of the Advanced Practitioner in Oncology},
  year = {2026},
  volume = {17},
  number = {2},
  doi = {10.6004/jadpro.2026.17.2.10}
}
Kostenlos starten →